A U.S. Supreme Court’s decision on Tuesday reinstates a requirement for patients to pick up the abortion drug mifepristone in person at a hospital or doctor’s office, regardless of the COVID-19 pandemic.

AUCKLAND, NEW ZEALAND – FEBRUARY 17: The abortion drug Mifepristone, also known as RU486, is pictured in an abortion clinic February 17, 2006 in Auckland, New Zealand. The drug, which has been available in New Zealand for four years and is used in many countries around the world, is expected to be available to Australian women within a year after parliament yesterday approved a bill which transfers regulatory control of the drug to the Therapeutic Goods Administration, a government body of scientists and doctors that regulates all other drugs in Australia. (Photo by Phil Walter/Getty Images)